Medications can be categorized by the type of condition they are used to treating. In 2023, revenues of anti-diabetes drugs in the United States amounted to approximately 35 billion U.S. dollars, which was only topped by anti-rheumatic and oncology drugs.
High demand for drugs to treat high blood pressure
In the United States, the therapeutic class with the most prescriptions was antihypertensives, which are effective in lowering blood pressure. Sales of antihypertensives generated around 12.4 billion U.S. dollars in 2023, representing just around two percent of the total amount of money spent on medicines in the United States during the year.
Counting the cost of diabetes
The number of prescriptions dispensed for the use of anti-diabetes drugs stood at 429 million in 2022; spending on anti-diabetic medicines increased over the last years. One reason for this could be a rise in the price of diabetes medications. When drug manufacturers own the patent to certain medicines, they can sell the product at a higher price because there is a lack of competition in the market. Prices start to fall when this market exclusivity ends, and generic versions enter the market.
Leading 10 U.S. therapy areas based on pharmaceutical revenue in 2023
(in billion U.S. dollars)
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Statista. (June 30, 2024). Leading 10 U.S. therapy areas based on pharmaceutical revenue in 2023 (in billion U.S. dollars) [Graph]. In Statista. Retrieved December 21, 2024, from https://www.statista.com/statistics/238698/us-pharma-revenue-by-leading-therapy-areas/
Statista. "Leading 10 U.S. therapy areas based on pharmaceutical revenue in 2023 (in billion U.S. dollars)." Chart. June 30, 2024. Statista. Accessed December 21, 2024. https://www.statista.com/statistics/238698/us-pharma-revenue-by-leading-therapy-areas/
Statista. (2024). Leading 10 U.S. therapy areas based on pharmaceutical revenue in 2023 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: December 21, 2024. https://www.statista.com/statistics/238698/us-pharma-revenue-by-leading-therapy-areas/
Statista. "Leading 10 U.S. Therapy Areas Based on Pharmaceutical Revenue in 2023 (in Billion U.S. Dollars)." Statista, Statista Inc., 30 Jun 2024, https://www.statista.com/statistics/238698/us-pharma-revenue-by-leading-therapy-areas/
Statista, Leading 10 U.S. therapy areas based on pharmaceutical revenue in 2023 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/238698/us-pharma-revenue-by-leading-therapy-areas/ (last visited December 21, 2024)
Leading 10 U.S. therapy areas based on pharmaceutical revenue in 2023 (in billion U.S. dollars) [Graph], Statista, June 30, 2024. [Online]. Available: https://www.statista.com/statistics/238698/us-pharma-revenue-by-leading-therapy-areas/
